{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:51:23Z","timestamp":1780534283435,"version":"3.54.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.transci.2011.10.003","type":"journal-article","created":{"date-parts":[[2011,10,22]],"date-time":"2011-10-22T23:26:40Z","timestamp":1319326000000},"page":"251-256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Experience with extracorporeal elimination therapy in myasthenia gravis"],"prefix":"10.1016","volume":"45","author":[{"given":"Milan","family":"Blaha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Pitha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Blaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Lanska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslav","family":"Maly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislav","family":"Filip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslav","family":"Brndiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Langrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.transci.2011.10.003_b0005","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1517\/14656560902950619","article-title":"Treatment strategies for myasthenia gravis","volume":"10","author":"D\u00edaz-Manera","year":"2009","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"10.1016\/j.transci.2011.10.003_b0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1055\/s-2004-829595","article-title":"Myasthenia gravis: management of myasthenic crisis and perioperative care","volume":"24","author":"Juel","year":"2004","journal-title":"Semin Neurol"},{"key":"10.1016\/j.transci.2011.10.003_b0015","doi-asserted-by":"crossref","unstructured":"Kumar V, Kaminski HJ. Treatment of myasthenia gravis. Curr Neurol Neurosci Rep 2010; 7. [Epub ahead of print].","DOI":"10.1007\/s11910-010-0151-1"},{"issue":"4","key":"10.1016\/j.transci.2011.10.003_b0020","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.nurt.2008.08.011","article-title":"Current and future standards in treatment of myasthenia gravis","volume":"5","author":"Gold","year":"2008","journal-title":"Neurotherapeutics"},{"issue":"11","key":"10.1016\/j.transci.2011.10.003_b0025","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00296-008-0579-7","article-title":"Associated thyreoiditis, myasthenia gravis, thymectomy. Crohn\u2019s disease, and erythema nodosum: pathogenetic and clinical correlations, immune system involvement, and systemic infectious complications","volume":"28","author":"Manfredi","year":"2008","journal-title":"Rheumatol Int"},{"issue":"4","key":"10.1016\/j.transci.2011.10.003_b0030","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0955-3886(94)90173-2","article-title":"Treatment of autoimmune disease by immunomodulation through extracorporeal elimination and intravenous immunoglobulin","volume":"15","author":"Borberg","year":"1994","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2011.10.003_b0035","doi-asserted-by":"crossref","unstructured":"Symonette CJ, Watson BV, Koopman WJ, Nicolle, Doherty TJ. Muscle strength and fatigue in patients with generalized myasthenia gravis. Muscle Nerve 2009; 7. [Epub ahead of print].","DOI":"10.1002\/mus.21493"},{"issue":"1","key":"10.1016\/j.transci.2011.10.003_b0040","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1526-0968.2003.00008.x","article-title":"Adsorption column for myasthenia gravis treatment: Medisorba MG-50","volume":"7","author":"Nakaji","year":"2003","journal-title":"Ther Apher Dial"},{"issue":"3","key":"10.1016\/j.transci.2011.10.003_b0045","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1744-9987.2009.00684.x","article-title":"Periodic therapeutic plasma exchange in patients with moderate to severe chronic myasthenia gravis non-responsive to immunosuppressive agents: an eight year follow-up","volume":"13","author":"Triantafyllou","year":"2009","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.transci.2011.10.003_b0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1567-5688(09)71804-5","article-title":"Extracorporeal LDL-cholesterol elimination (25 years of experience)","volume":"10","author":"Bl\u00e1ha","year":"2009","journal-title":"Atherosclerosis Suppl"},{"issue":"1","key":"10.1016\/j.transci.2011.10.003_b0055","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0955-3886(00)00126-0","article-title":"The current state of extracorporeal haemorheotherapy: from haemodilution via cascadefiltration to rheohaemapheresis","volume":"24","author":"Borberg","year":"2001","journal-title":"Transfus Apher Sci"},{"issue":"1","key":"10.1016\/j.transci.2011.10.003_b0060","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.transci.2009.05.013","article-title":"28 years of LDL-apheresis: a review of experience","volume":"41","author":"Borberg","year":"2009","journal-title":"Transfus Apher Sci"},{"issue":"3","key":"10.1016\/j.transci.2011.10.003_b0065","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/jca.20129","volume":"22","author":"Szczepiorkowski","year":"2007","journal-title":"J Clin Apher"},{"issue":"3","key":"10.1016\/j.transci.2011.10.003_b0070","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jca.20240","volume":"25","author":"Szczepiorkowski","year":"2010","journal-title":"J Clin Apher"},{"issue":"3","key":"10.1016\/j.transci.2011.10.003_b0075","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ejcts.2008.11.006","article-title":"Plasmapheresis before thymectomy in myasthenia gravis: routine versus selective protocols","volume":"35","author":"El-Bawab","year":"2009","journal-title":"Eur J Cardiothorac Surg"},{"issue":"2","key":"10.1016\/j.transci.2011.10.003_b0080","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1744-9987.2009.00751.x","article-title":"Comparing the autoantibody levels and clinical efficacy of double filtration plasmapheresis, immunoadsorption, and intravenous immunoglobulin for the treatment of late-onset myasthenia gravis","volume":"14","author":"Liu","year":"2010","journal-title":"Ther Apher Dial"},{"issue":"4","key":"10.1016\/j.transci.2011.10.003_b0085","first-page":"478","article-title":"Plasmapheresis or intravenous immunoglobulin for myasthenia gravis crisis in King Chulalongkorn Memorial Hospital","volume":"92","author":"Pittayanon","year":"2009","journal-title":"J Med Assoc Thai"},{"issue":"12","key":"10.1016\/j.transci.2011.10.003_b0090","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1468-1331.2009.02729.x","article-title":"Changes in serum cytokine levels during plasmapheresis in patients with myasthenia gravis","volume":"16","author":"Yeh","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.transci.2011.10.003_b0095","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1586\/ern.09.81","article-title":"Plasmapheresis for neurological disorders","volume":"9","author":"Schr\u00f6der","year":"2009","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.transci.2011.10.003_b0100","doi-asserted-by":"crossref","unstructured":"Kumar V, Kaminski HJ. Treatment of myasthenia gravis. Cur Neurol Neurosci Rep. Published online: 07 October 2010.","DOI":"10.1007\/s11910-010-0151-1"},{"key":"10.1016\/j.transci.2011.10.003_b0105","first-page":"196","article-title":"Therapeutic apheresis in neurological disorders: a survey of the evidence in support of current category I a II indications for therapeutic plasma exchange","volume":"23","author":"Weinstein","year":"2008","journal-title":"Ther Apher Dial"},{"issue":"6","key":"10.1016\/j.transci.2011.10.003_b0110","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/jca.20217","article-title":"Predictors of complications in therapeutic plasma exchange","volume":"24","author":"Bramlage","year":"2009","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2011.10.003_b0115","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1744-9987.2005.00319.x","article-title":"Complications of therapeutic plasma exchange: experience with 4857 treatments","volume":"9","author":"Basic-Jukic","year":"2005","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.transci.2011.10.003_b0120","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/jca.20143","article-title":"Complications of plasma exchange: a prospective study of 1727 procedures","volume":"22","author":"Shemin","year":"2007","journal-title":"J Clin Apher"},{"issue":"4","key":"10.1016\/j.transci.2011.10.003_b0125","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/jca.20059","article-title":"Therapeutic plasma exchange as a nephrological procedure: a single-center experience","volume":"20","author":"Yeo","year":"2005","journal-title":"J Clin Apher"},{"issue":"1","key":"10.1016\/j.transci.2011.10.003_b0130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1744-9987.2007.00450.x","article-title":"Safety and tolerability of long lasting LDL-apheresis in familial hyperlipoproteinemia","volume":"11","author":"Bl\u00e1ha","year":"2007","journal-title":"Ther Apher Dial"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050211001650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050211001650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:48:48Z","timestamp":1761468528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050211001650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1473050211001650"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2011.10.003","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experience with extracorporeal elimination therapy in myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2011.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}